#Corneal regenerative surgery

[lifebiologicsusa]

The Role of Innovative Amniotic Tissue Companies in Modern Medicine

In the ever-evolving field of regenerative medicine, innovative amniotic tissue companies are at the forefront of providing advanced solutions for wound healing, surgical procedures, and pain management. Amniotic tissue, derived from the innermost layer of the placenta, has remarkable healing properties that have made it a game-changer in the medical field. With its unique ability to promote tissue regeneration and reduce inflammation, this natural resource is transforming patient outcomes across the United States.

What Is Amniotic Tissue?

Amniotic tissue consists of the amniotic membrane and fluid that surround and protect a developing fetus during pregnancy. This tissue is rich in growth factors, cytokines, and extracellular matrix components, all of which contribute to its powerful healing capabilities. It also has anti-inflammatory, antimicrobial, and anti-scarring properties, making it an ideal material for a wide range of medical applications.

Amniotic tissue is commonly used in:

Wound Healing: To treat chronic wounds, burns, and diabetic ulcers.

Ophthalmology: For repairing corneal injuries and other eye conditions.

Orthopedics: To manage pain and inflammation in joint and soft tissue injuries.

Surgery: To enhance healing in complex surgical procedures.

The Work of Amniotic Tissue Companies

Amniotic tissue companies are responsible for collecting, processing, and distributing this valuable medical resource. They follow stringent guidelines to ensure the tissue is ethically sourced and processed in a way that preserves its therapeutic properties. Donors are carefully screened, and the tissue is sterilized and cryopreserved to ensure safety and efficacy.

These companies also invest heavily in research and development to expand the applications of amniotic tissue. From developing advanced wound dressings to injectable amniotic products for orthopedic use, their innovations are pushing the boundaries of what regenerative medicine can achieve.

Benefits of Amniotic Tissue in Medicine

The use of amniotic tissue in medical treatments offers numerous benefits:

Accelerated Healing: Amniotic tissue provides an ideal environment for cell growth and tissue regeneration, leading to faster recovery times.

Reduced Inflammation: Its natural anti-inflammatory properties help manage pain and swelling, improving patient comfort.

Lower Risk of Rejection: Since amniotic tissue is immunoprivileged, it minimizes the risk of immune response or rejection.

Versatile Applications: From treating wounds to reducing post-surgical complications, its uses are vast and growing.

Minimized Scarring: Amniotic tissue promotes natural healing processes while reducing the formation of scar tissue.

Innovations Driving the Future

Amniotic tissue companies are continually innovating to improve the accessibility and efficacy of their products. Advances in biotechnology have enabled the creation of injectable amniotic products, which are particularly beneficial in orthopedics for treating joint pain and soft tissue injuries. These products are minimally invasive and deliver targeted healing benefits directly to the affected area.

Furthermore, companies are exploring the potential of amniotic tissue in regenerative therapies for conditions such as arthritis, spinal injuries, and even hair restoration. These cutting-edge applications demonstrate the vast potential of this natural resource in improving patient outcomes.

Challenges and Accessibility

While the benefits of amniotic tissue are undeniable, challenges remain. The cost of these treatments can be prohibitive for some patients, and insurance coverage is not always guaranteed. Additionally, the process of sourcing and processing amniotic tissue requires rigorous adherence to ethical and regulatory standards, which can impact availability.

To address these challenges, leading companies are working to make amniotic tissue products more affordable and accessible. This includes increasing awareness among healthcare providers, partnering with insurance companies, and investing in cost-effective processing methods.

Conclusion

Advanced solutions provided by amniotic tissue companies are revolutionizing healthcare, offering hope and healing to patients across the United States. With their commitment to innovation, safety, and accessibility, companies like Life Biologics are leading the charge in harnessing the power of amniotic tissue for the betterment of modern medicine. As research and technology continue to evolve, the potential for this incredible resource will only grow, ensuring a brighter future for patients in need.

Read More :- https://biologicslife.wixsite.com/lifebiologicsusa/post/exploring-advanced-skin-substitutes-for-wound-healing-1

[eyerootseyeclinic]

Smile Eye Surgery Clinic

When it comes to maintaining and improving your vision, having access to world-class eye care services is crucial. In the bustling city of New Delhi, two leading eye clinics have emerged as beacons of excellence - the  Smile Eye Surgery Clinic and the Eyeroots Eye Clinic. These state-of-the-art facilities are spearheading a revolution in ophthalmic care, delivering cutting-edge treatments and personalized attention to patients from all walks of life.

The Smile Eye Surgery Clinic: Where Innovation Meets Compassion

Established with a vision to provide the highest caliber of eye care, the Smile Eye Surgery Clinic has quickly risen to prominence in New Delhi's medical landscape. Led by a team of renowned ophthalmologists and supported by a dedicated support staff, this clinic has become synonymous with exceptional patient outcomes and unwavering commitment to patient well-being.

One of the key pillars of the Smile Eye Surgery Clinic's success is its relentless pursuit of innovative techniques and technologies. The clinic's doctors are constantly researching and implementing the latest advancements in the field of ophthalmology, ensuring that their patients have access to the most effective and safe treatments available.

"At the Smile Eye Surgery Clinic, we believe that cutting-edge technology and personalized care go hand-in-hand," says Dr. Niharika Khute, the clinic's Medical Director. "Our patients deserve the very best, and that's exactly what we strive to deliver – a seamless blend of medical excellence and empathetic, patient-centric approach."

The clinic's impressive array of services encompasses a wide range of eye care procedures, from routine eye exams and vision correction surgeries to complex treatments for conditions like cataracts, glaucoma, and retinal disorders. Patients can rest assured that they are in the hands of true experts, as the Smile Eye Surgery Clinic's team has collectively performed thousands of successful surgeries and treatments.

But the clinic's commitment to excellence extends far beyond the operating room. The Smile Eye Surgery Clinic is renowned for its warm and welcoming atmosphere, where patients are treated like family. From the moment they step through the doors, patients are greeted with a genuine smile and a genuine concern for their well-being. The clinic's staff goes above and beyond to ensure that every patient feels comfortable, informed, and confident in the care they are receiving.

"We understand that seeking medical treatment can be a daunting experience, especially for those who may be apprehensive about eye surgery," says Dr. Niharika Khute. "That's why we've created an environment that prioritizes patient comfort and empowerment. Our goal is to not only restore our patients' vision, but to also restore their sense of confidence and well-being."

Eyeroots Eye Clinic: Redefining the Future of Eye Care

Nestled in the heart of New Delhi, the Eyeroots Eye Clinic is a true beacon of innovation in the field of ophthalmology. Helmed by a team of visionary doctors and researchers, this state-of-the-art facility is at the forefront of cutting-edge treatments and groundbreaking discoveries.

One of the clinic's most impressive achievements is its pioneering work in the field of stem cell therapy for eye diseases. By harnessing the regenerative power of stem cells, the Eyeroots team has developed innovative treatments that have the potential to revolutionize the way we approach conditions like macular degeneration, retinal damage, and even corneal blindness.

"We firmly believe that the future of eye care lies in the incredible potential of stem cell technology," says Dr. Niharika Khute, the Eyeroots Eye Clinic's Director of Research. "Our team has dedicated countless hours to exploring the boundaries of what's possible, and we're thrilled to be able to offer our patients access to these transformative treatments."

But the Eyeroots Eye Clinic's commitment to innovation extends far beyond stem cell therapy. The clinic is also at the forefront of other cutting-edge treatments, such as laser-assisted cataract surgery, advanced glaucoma management, and personalized vision correction procedures.

What sets the Eyeroots Eye Clinic apart, however, is its unwavering dedication to patient-centric care. The clinic's doctors and staff understand that every patient is unique, with their own set of needs, concerns, and goals. That's why they take the time to listen, understand, and develop a tailored treatment plan that addresses each individual's specific requirements.

"At Eyeroots, we believe that the key to successful eye care is a deep understanding of our patients," says Dr. Niharika Khute. "We don't just treat the condition – we treat the person. Our goal is to not only restore vision, but to also empower our patients to live their best lives."

This commitment to personalized care is evident in every aspect of the Eyeroots Eye Clinic experience. From the warm and welcoming reception area to the state-of-the-art diagnostic and treatment facilities, every detail has been designed with the patient's comfort and well-being in mind.

But perhaps the most impressive aspect of the Eyeroots Eye Clinic is its dedication to community outreach and education. The clinic's team of experts regularly participates in public awareness campaigns, providing free eye screenings and educational workshops to underserved communities in New Delhi.

"We firmly believe that eye care is a fundamental human right," says Dr. Niharika Khute. "That's why we're committed to making our services accessible to everyone, regardless of their socioeconomic status or geographic location."

Redefining the Future of Eye Care in New Delhi

Whether you're seeking a routine eye exam, a complex surgical procedure, or cutting-edge stem cell therapy, the Smile Eye Surgery Clinic and the Eyeroots Eye Clinic are the destinations of choice for discerning patients in New Delhi.

These two exceptional facilities are not just changing the face of eye care in the city – they are redefining the very future of the field. With their unwavering commitment to innovation, personalized attention, and community outreach, the Smile Eye Surgery Clinic and the Eyeroots Eye Clinic are setting a new standard of excellence that is sure to inspire and influence the entire industry.

So if you're looking to take charge of your eye health and vision, look no further than these two remarkable institutions. With their expert teams, state-of-the-art facilities, and unparalleled dedication to patient well-being, the Smile Eye Surgery Clinic and the Eyeroots Eye Clinic are poised to become the go-to destinations for eye care in New Delhi and beyond.

[trendingreportz]

Tissue Banking Market - Forecast(2024 - 2030)

Tissue Banking Market Overview

The market size of Global Tissue Banking for 2019 is $42,599m and is set to grow at a CAGR of 4.0% during the forecast period 2020–2025 owing to a rise in tissue transplant cases and rising incidences of cancers, cardiovascular diseases, and diabetes. The market is witnessing several trends such as a shift in public perception toward cord tissue and blood storage, improving techniques for the use of cord tissues in cellular therapy, and potential cure for cancers, blood disorders, and immune and genetic diseases. With the increase in the harmonization of biobanks and research collaboration, the tissue banking market is set to grow positively during the forecast period. 

Key Takeaways

The global tissue banking market is poised to exhibit a CAGR of 4.0% percentage during the forecast period (2020–2025), attributed to rising demand for transplantation.

Major factors driving growth of the global tissue banking market is increase in the demand for regenerative medicines. 

The wide range of applications for instance storage, handling, transportation and maintenance of specimens and samples is poised to increase the market growth for the forecast period.

Request Sample

By Type - Segment Analysis

In Tissue Type segment, Blood tissue accounted for the largest share, followed by soft tissue in 2019. Blood donation has increased substantially in the past few years. In U.S., approximately 36,000 units of red blood cells are needed everyday. In Europe, approximately 1700 people opted for blood vessel tissue donation in 2013. The countries such as Spain, Italy and Sweden are the major countries with high number of donors.

By Equipment - Segment Analysis

In Equipment type, Cryopreservation Systems segment dominated the market in 2019. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities which are to be used for procedures such as organ donation, bone marrow transplant and others. 

Inquiry Before Buying

By Application - Segment Analysis 

In 2019, Clinical/ Therapeutic dominated the Application segment of Tissue banking market and is set to grow at a CAGR of 4.3%. Tissues preserved in tissue banks can be used for fulfilling variety of medical needs of people for example heart valves can be used in patients with heart disorders, corneal transplantation used to give visibility to blind people, tendons and ligaments used in  orthopedic surgery and blood to treat blood disorders. Clinical/therapeutic applications majorly use tissue banking for it involves different types of grafting such as cord blood, stem cell and others. 

By Geography - Segment Analysis

North America region held 35% of the global tissue banking market in 2019. This is owing to advanced technology and high awareness regarding tissue donation among the medical personnel and healthcare professionals. Europe is set to attain a significant growth owing to the increasing geriatric population and unhealthy lifestyle prevailing in the region. Asia-Pacific is poised to record rapid growth rates on the account of government initiatives for expanding medical facilities coupled with the presence of key market players in the region.

Schedule a Call

Drivers – Tissue Banking Market

Increasing Technological Advancement

Technological advancement in the healthcare sector such as development in biobanking technology coupled with a rise in regenerative tissue demand drives the market growth. The regenerative medicines cure different kinds of damaged tissues covering aging issues to injuries, which is poised to drive the demand for the Tissue Banking Market.

Challenges – Tissue Banking Market

High Cost Associated With Transplantation Procedures

The high transplant cost, bioethical issues and unavailability of tissue banks in many remote countries coupled with stringent government rules and regulations regarding testing and clearance documents negatively impact the growth of the global tissue banking market over the forecast period. 

Buy Now

The Major Players in this Market Include

The leading players in the tissue banking market are AMS Biotechnology (Europe) Limited, Avantor, Inc (VWR International), BioCision LLC, Brooks Automation, Custom Biogenic Systems, Eppendorf AG, Hamilton Company, Merck KGaA and Thermo Fisher Scientific, Inc.

Acquisitions/Product Launches:

In 2017, Natera, a leader in genetic testing, launched Evercord, a new offering that enables expectant parents to collect, store, and potentially retrieve their newborn’s cord, blood, and tissue for therapeutic use in transplantation and regenerative medicine applications.

In 2013, three institutes at the National Institute of Health, including the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Child Health and Human Development (NICHD) launched a joint initiative called as ‘NeuroBioBank’ in the U.S. It links together six large organ and tissue repositories through a common web portal.

In October 2018, MTF Biologics announced the formation of a new tissue recovery relationship with Regenerative Biologics, Inc. The organizations seek to provide expanded birth-tissue donation opportunities for expectant mothers and their families and enhance patients’ access to high-quality placental tissues for wound care applications.

[crossborderscare]

Cornea Transplant Surgery: Beyond Darkness

Vision is a remarkable gift that allows us to experience the world around us in vivid detail, capturing the beauty of nature, the faces of loved ones, and the intricate patterns of life. However, for many individuals, the world remains shrouded in darkness due to corneal disorders that impair their ability to see clearly. Cornea transplant surgery, also known as corneal transplantation or keratoplasty, has emerged as a beacon of hope for those seeking to escape this darkness and regain the gift of sight.

The Cornea: Window to the World

The cornea is the clear, dome-shaped surface at the front of the eye that acts as a protective barrier and plays a critical role in focusing light onto the retina. It is responsible for a significant portion of the eye's refractive power, aiding in the formation of clear images. However, various factors such as injury, infection, genetic conditions, and degenerative diseases can damage the cornea, leading to visual impairment and even blindness.

Unveiling the Surgical Solution

Cornea transplant surgery has revolutionized the treatment of corneal disorders, offering a ray of hope to those whose vision has been compromised. This surgical procedure involves the replacement of the damaged or diseased cornea with a healthy cornea from a deceased donor. The surgery can be a partial-thickness transplant (where only a portion of the cornea is replaced) or a full-thickness transplant (where the entire cornea is replaced).

Types of Cornea Transplant Surgeries:

Penetrating Keratoplasty (PKP): This is the traditional full-thickness cornea transplant, where a circular section of the central cornea is removed and replaced with a donor cornea. PKP is suitable for cases of severe corneal scarring or disease affecting multiple layers of the cornea.

Endothelial Keratoplasty (EK): EK includes techniques like Descemet's Stripping Endothelial Keratoplasty (DSEK) and Descemet's Membrane Endothelial Keratoplasty (DMEK). These procedures target the innermost layer of the cornea, called the endothelium. EK is preferred when only the endothelial layer is affected, as it allows for faster visual recovery and reduced risk of complications.

Deep Anterior Lamellar Keratoplasty (DALK): DALK involves removing the front layers of the cornea while leaving the endothelial layer intact. This technique is suitable for cases where the disease primarily affects the outer layers of the cornea.

Beyond Darkness: Transforming Lives

The impact of cornea transplant surgery on patients' lives cannot be overstated. For many individuals, the surgery means moving from a life of limited sight or blindness to one of renewed clarity and independence. The procedure not only enhances visual acuity but also improves the quality of life by enabling individuals to participate more fully in daily activities, pursue careers, and engage in hobbies they may have thought were lost forever.

However, the journey from darkness to light is not without its challenges. Finding suitable donor corneas, post-operative care, and the potential for rejection are all factors that must be carefully managed to ensure the long-term success of the surgery.

A Glimpse into the Future

Advancements in medical technology continue to propel cornea transplant surgery forward. Researchers are exploring innovative techniques to enhance graft survival rates, reduce the need for long-term medications, and improve visual outcomes. Additionally, regenerative medicine and tissue engineering are on the horizon, holding the promise of creating lab-grown corneal tissue to eliminate the need for donor corneas altogether.

Conclusion

Cornea transplant surgery stands as a testament to human ingenuity and compassion, offering a lifeline to those trapped in a world of darkness. Through the expertise of skilled surgeons, the generosity of donors, and the resilience of patients, this surgical procedure has transformed countless lives, reaffirming the power of medical science to bring light to the shadows. As technology continues to evolve, the journey from darkness to vision promises to become even more remarkable, guiding individuals towards a future filled with vibrant colors, breathtaking vistas, and the boundless beauty of the world around them.

[healthcare-23]

Advances in Eye Surgery: Enhancing Vision

Eye surgery encompasses a wide range of procedures aimed at addressing various ocular conditions and improving visual acuity. This article explores the advancements in eye surgery, including cataract surgery, corneal transplant, refractive surgeries, and retinal surgeries. It delves into the evolving techniques, emerging technologies, improved outcomes, and the impact of these advancements on the quality of life for patients. By understanding the progress in eye surgery, readers will gain insight into the innovative approaches and transformative possibilities offered by modern ophthalmology.

I. Cataract Surgery Advancements

Cataract surgery has undergone significant advancements over the years, leading to improved surgical techniques and outcomes. This section explores the evolution of cataract surgery, from extracapsular extraction to phacoemulsification. It discusses the introduction of microincision techniques, advanced intraocular lens (IOL) options, and the use of femtosecond laser-assisted cataract surgery. Additionally, it explores the integration of biometry technologies for precise IOL power calculations and the development of extended depth of focus and multifocal IOLs, allowing patients to achieve better visual outcomes and reduced dependence on glasses.

II. Corneal Transplant Innovations

Corneal transplant surgery has witnessed significant advancements in recent years, contributing to improved outcomes and increased accessibility. This section explores the development of lamellar keratoplasty techniques, such as Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK), which provide more targeted and minimally invasive approaches for addressing corneal disorders. It also discusses the use of preloaded donor tissues, advanced surgical instruments, and selective corneal transplantation, optimizing surgical efficiency and enhancing graft survival rates. Additionally, it highlights ongoing research in tissue engineering and regenerative medicine, holding promise for future innovations in corneal transplantation.

III. Refractive Surgeries and LASIK Advancements

Refractive surgeries, such as LASIK (Laser-Assisted in Situ Keratomileusis), have undergone significant advancements, revolutionizing the treatment of refractive errors. This section explores the improvements in LASIK techniques, including the use of femtosecond lasers for creating corneal flaps, wavefront-guided treatments for personalized corneal reshaping, and topography-guided treatments for addressing irregular astigmatism. It discusses advancements in corneal biomechanics assessment, corneal collagen cross-linking, and the integration of artificial intelligence for precise surgical planning. These advancements have led to enhanced visual outcomes, reduced postoperative complications, and increased patient satisfaction.

IV. Retinal Surgery Innovations

Retinal surgery has witnessed notable advancements in the treatment of retinal disorders, such as retinal detachment and macular diseases. This section explores the use of microincision vitrectomy surgery (MIVS) techniques, allowing for smaller incisions, reduced postoperative discomfort, and faster recovery. It discusses the integration of intraoperative imaging technologies, such as optical coherence tomography (OCT), aiding in real-time visualization and precise surgical maneuvers. Furthermore, it highlights the use of advanced retinal implants and gene therapy approaches for treating retinal degenerative diseases, offering potential solutions for previously untreatable conditions.

V. Challenges and Future Direction

While significant advancements have been made in eye surgery, several challenges remain. This section discusses the challenges of increasing accessibility to advanced surgical techniques, managing postoperative complications, addressing cost limitations, and ensuring long-term success and safety. It also explores future directions, including ongoing research in stem cell therapy, artificial intelligence applications, and nanotechnology for targeted drug delivery. These advancements hold promise for further improving surgical outcomes, expanding treatment options, and ultimately transforming the field of eye surgery.

Conclusion

Advancements in eye surgery have revolutionized the field of ophthalmology, offering new hope and improved outcomes for patients with various ocular conditions. Eye surgery in India has seen advancements in various areas, including cataract surgery techniques, corneal transplant procedures, refractive surgeries like LASIK, and the adoption of advanced technologies for improved outcomes. Through the progress in cataract surgery, corneal transplant, refractive surgeries like LASIK, and retinal surgeries, the quality of life for individuals experiencing visual impairments has significantly improved. However, challenges remain, and ongoing research and collaboration are essential to overcome these hurdles and continue pushing the boundaries of eye surgery. By embracing emerging technologies, refining surgical techniques, and addressing accessibility, eye surgeons can continue to enhance vision, restore clarity, and make a lasting impact on the lives of patients.

[materialsscienceandengineering]

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors

Thin tissue grafts and flexible electronics have a host of applications for wound healing, regenerative medicine and biosensing. A new device inspired by an octopus's sucker rapidly transfers delicate tissue or electronic sheets to the patient, overcoming a key barrier to clinical application, according to researchers at the University of Illinois at Urbana-Champaign and collaborators.

"For the last few decades, cell or tissue sheets have been increasingly used to treat injured or diseased tissues. A crucial aspect of tissue transplantation surgery, such as corneal tissue transplantation surgery, is surgical gripping and safe transplantation of soft tissues. However, handling these living substances remains a grand challenge because they are fragile and easily crumple when picking them up from the culture media," said study leader Hyunjoon Kong, a professor of chemical and biomolecular engineering at Illinois.

Kong's group, along with collaborators at Purdue University, the University of Illinois at Chicago, Chung-Ang University in South Korea, and the Korea Advanced Institute for Science and Technology, published their work in the journal Science Advances.

Read more.

[theleaderdotinfo-blog]

Elche professor guest of honour at Asia-Pacific Academy of Ophthalmology Congress has been published at http://www.theleader.info/2018/02/13/elche-professor-guest-honour-asia-pacific-academy-ophthalmology-congress/

New Post has been published on http://www.theleader.info/2018/02/13/elche-professor-guest-honour-asia-pacific-academy-ophthalmology-congress/

Elche professor guest of honour at Asia-Pacific Academy of Ophthalmology Congress

Jorge Alió shared his experience in symposiums and debates at the 33rd Asia-Pacific Academy of Ophthalmology Congress Dr. Jorge Alió went to Asia to participate in the 33rd Asia-Pacific Academy of Ophthalmology Congress (APAO), which this year took place from 8 to 11 February in Hong Kong, held in conjunction with the 29th Hong Kong Ophthalmological Symposium. [caption id="attachment_17957" align="aligncenter" width="1134"] Dr. Alió gave two speeches on correction of presbyopia and its future, as well as a symposium on cataract surgery[/caption] During this meeting Jorge Alió, the professor of the Miguel Hernandez University of Elche (UMH), had a great opportunity to share his knowledge in corneal regenerative surgery at the Faculty of Medicine of the Chinese city. Moreover, he gave two speeches on correction of presbyopia and its future, as well as a symposium on cataract surgery. It should be mentioned that Jorge Alió is the creator of the concept of microincisional cataract surgery (MICS). It should also be remembered that Dr. Jorge Alió´s team, formed by Dr. Alio del Barrio, Dr. Mona El Zarif, Dr. Maria de Miguel and other collaborators, has published the first work in the world on stem cells therapy for corneal regeneration in the ‘American Journal of Ophthalmology’. This research is a result of a year of an international study organized and directed by Dr. Alió. The research has demonstrated that it is possible to use adipose-derived stem cells, taken from the patient's own eyes, to regenerate the cornea in cases of chronic diseases, in which corneal transplantation was the unique alternative. In 2016 Dr. Alió was already awarded the 'Achievement Award' at this event, presented by Clement Tham, Secretary-General of APAO Council. This year Jorge Alió has been able to interact with other prestigious professionals such as Chales McGhee, president of APAO; John Chang, current president of the ISRS (International Society of Refractive Surgery), which Alió has been chairing for several years now; Dennis Lam, the president of the Council of the Asia-Pacific Academy of Ophthalmology; and Amar Agarwal, eminent figure in the world of ophthalmology; among other important personalities of Chinese ophthalmology. Finally, it should be noted that according to the Top Doctors rating, Jorge Alió has been recognized as one of the best physicians in Spain, due to his constant study and dedication. Furthermore, in 2015 he was presented with prestigious ‘ISRS Presidential Award’ by the American Academy of Ophthalmology (AAO) for his dedication and contribution to the field of refractive surgery and the International Society of Refractive Surgery. In addition, just recently Vision Spain association has awarded Dr. Jorge Alió with the Presidency of Honor.

[tritonmarketresearch]

Amniotic Membrane Market: Significance & Global Performance

Amniotic membrane or amnion, a thin membrane on the inner side of the fetal placenta and composed of the epithelium, has emerged as an ideal source for tissue transplantation. Moreover, amnion has an array of biological properties, making it attractive for use in various surgical procedures, including ocular surface reconstruction and tissue engineering.

The advancements in anatomy have triggered significant investments in research and development of amniotic membrane applications. While AM has shown beneficial results in burn injuries, the upsurge in R&D investments has increased its use in eye surgery, cell therapy, stem cell research, and more, boosting the amniotic membrane market growth prospects.

In fact, the identification of new stem cells has increased the membrane’s potential, making it ideal for developing regenerative medicines. For instance, Organogenesis Holdings Inc, a leading regenerative medicine company, gained approval from the US FDA for ReNu, a cryopreserved amniotic suspension allograft, to manage symptoms related to knee osteoarthritis.

Amniotic Membrane Market - Global & Regional Trends

As per estimates, the global amniotic membrane market will display revenue growth at a CAGR of 7.01% during the forecast period 2022-2028.

Considering the evolving healthcare sector, the amniotic membrane market is expected to witness tremendous growth in the Asia-Pacific nations. Estimates suggest that approximately half a billion people in the region will be 65 or older by 2025. This change in demographics, in addition to a shift in consumer expectations, will widen the market’s scope. In this regard, the growing demand for chronic care management will expand amnion application in ophthalmology, burn injuries, and cosmetic surgeries, among others.

Additionally, amniotic membrane transplantation has gained momentum in various conjunctival and corneal diseases, signaling opportunistic growth for players in the APAC region. Considering its growth in North America, amnions have proven advantageous in treating limbal stem cell deficiency, providing support and protection to transplanted limbal tissues and stem cells. Recently, in Canada, numerous techniques have been developed to dehydrate amnion while preserving the wound-healing properties to formulate a temperature-stable allograft.

Furthermore, the United Kingdom is the center of research and development of amniotic membrane applications in Europe. Several hospitals, such as NuVision, have gained expertise in providing AM treatments. Amniotic membrane treatments are gaining center stage across the nation, given the technological advancements. For instance, in November 2021, several ophthalmologists shared their innovations of AM application in treating ocular surface conditions through a webinar sponsored by NuVision Biotherapies Ltd.

Market by Application – Expert Outlook

Surgical Wounds: Human amniotic membrane has been used for treating acute and chronic wounds, decreasing infection and pain while accelerating the healing time. The surgical wound segment dominates the overall market and is expected to maintain its stronghold till 2028. Although a plethora of wound dressings are available, chronic wounds remain a major medical concern. As a result, chronic wounds awareness programs largely support amnion application. For instance, the Wound Healing and Hyperbaric Center at Carteret Health Care, a Healogic Network member, is engaged in raising awareness of chronic wounds, providing advanced therapies.

Ophthalmology: The rise in chronic and infectious diseases has resulted in a global rise in surgeries, boosting the market’s potential. Amniotic membrane is rapidly used in ophthalmic surgeries to initiate faster recovery and decrease inflammation. Amnion has become crucial in eye treatments, given its anti-scarring and anti-inflammatory properties. For instance, Bio Tissue Inc offers AmnioGraft to treat ocular surface indications like corneal ulcers, dry eye, chemical burns, etc. Besides, AM is highly preferred in developing regions since it is cheaper than allografts.

Competitive Analysis

For any company, acquisitions and agreements ensure expansion in business footings. Acquisitions, for instance, are quicker, cheaper, and less risky compared to other methods to extend volume sales. On the other hand, agreements are crucial to eliminating disagreements, confusion, or changes that may transpire during the course of the business period.

Notable acquisitions and agreements that support the market’s development:

In February 2021, Katena Products Inc, a leading provider of premium ophthalmic instruments and devices, announced the acquisition of ASICO LLC to expand the ophthalmic surgical product line and lead in the innovation of new products.

Integra LifeSciences Corporation, in January 2021, acquired ACell Inc and its proprietary MatriStem UMB to offer comprehensive wound management solutions.

Celularity Inc and Oncternal Therapeutics Inc entered into a research partnership in September 2021 to examine placental-derived cellular treatments.

Celularity also collaborated with Imugene Ltd in August 2021 to employ Imugene’s CD19 oncolytic virus technology and its CD19 CYCART-19 to remedy solid tumors.

In Conclusion,

The amniotic membrane market has shown rapid and promising results in healing damaged tissues. From chemical burns to ulcers to the cornea, amnions have emerged as suitable membranes in wound care management. This indicates that the use of AM in medicine and therapies is expanding in various branches of medicine.

[nikhilghodse20051994]

Amniotic Membrane Market Opportunities And Key Insights 2022

According to our new market research study titled ”Amniotic Membrane Market –Global Analysis and Forecast – by Enzyme, Application, and End User” the global amniotic membrane market is expected to reach US$ 2,577.74 million by 2027 from US$ 1,484.83 million in 2019; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report highlights the trends prevalent in the global amniotic membrane market, and the drivers and deterrents pertaining to its growth.

The growth of the market is attributed to the factors such as growing applications of amniotic membrane and rising number of target patient population. However, the challenges in using amniotic membranes such compatibility are expected to hinder the market growth.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis –

Applied Biologics LLC; Integra Life Sciences Corporation; Skye Biologics Inc.; MiMedx; Organogenesis Inc.; Smith & Nephew; Amniox Medical, Inc.; Katena Products. Inc.; Amnio Technology, LLC; and Surgenex, LLC are among the prominent players operating in the amniotic membrane market. The market players are focused on organic strategies to sustain their position in the market. For instance, in August 2020, TissueTech, Inc.’s proprietary PROKERA Slim corneal bandage, an amniotic membrane medical device was approved for eye care professionals’ use in Taiwan.

The amniotic membrane-derived products are widely used in regenerative medicine. Moreover, several  players operating in this market have developed and are developing amniotic membrane-derived products. For instance, SURGENEX, LLC, headquartered in the US, offers SurGraft a dehydrated amniotic membrane sheet that has a wide application in wound management, ophthalmology, orthopedic surgery, and podiatry. It also provides SurFactor, an injectable amniotic tissue allograft that offers protective cushion to the damaged joints, tendons, cartilage, ligaments, and other soft tissues. Additionally, the company offers SurForce, a highly concentrated, cryopreserved, minimally manipulated, and biological injectable.

Click here to avail lucrative discounts on our latest reports. We offer student, enterprise, and special periodic discounts to our clientele. Please fill the inquiry form below to know more -

Similarly, the US-based Genesis Biologics provides amniotic fluid and amniotic membrane products that  are used to treat conditions such as inflamed nerves, intra-articular pain, muscle tears, plantar fasciitis, repetitive motion injuries, soft tissue injuries, and tendonitis.

Further, an-vision GmbH, headquartered in Germany, offers Vetrix EyeQ amniotic eye drops that provides superior healing environment suitable for corneal tissue repair.

The report segments the global amniotic membrane market as follows:

 By Enzyme

Cryopreserved Amniotic Membrane

Dehydrated Amniotic Membrane

By Application

Surgical Wounds

Ophthalmology

Others

By End User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Research Institute and Academic Institutes

By Geography

North America

US

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Asia Pacific (APAC)

Japan

China

India

Australia

South Korea

Middle East and Africa (MEA)

South Africa

UAE

Saudi Arabia

South and Central America (SCAM)

Brazil

Argentina

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods -

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

[shreyas-inkwood]

Amniotic Membrane Market: Product and Application Outlook

Globally, burn cases, trauma wounds, and surgeries are on the rise. According to the Global Burden of Disease, almost 90 million burn cases were registered worldwide in 2017. The amniotic membrane’s anti-inflammatory and anti-scarring properties have been instrumental in reducing discomfort and inflammation, thereby contributing to its resurging use in multiple applications. Subsequently, the increased awareness regarding product innovations and benefits has significantly impacted AM’s expansion. As per Inkwood Research analysis, the global amniotic membrane market is projected to evolve at 7.03% of CAGR between 2022 and 2030.

Amniotic Membrane: Structure and Function

The amniotic membrane comprises several layers and can be divided into two different layers, the chorion and amnion, further separated by a jelly-like layer. It entails three material types, regenerative molecules, biologically active cells, and collagen and extracellular matrix. Collagen adds structural strength to the membrane, whereas extracellular matrix provides structure and has specialized proteins like laminins, fibronectin, proteoglycans, etc.

Further, biologically active cells comprise stem cells that revitalize new cellular materials within the membrane lining. Regenerative molecules are central to growth and healing, encompassing metalloproteinases, platelet-derived growth factors, and fibroblast growth factors.

Amniotic Membrane Market by Application

Amniotic membrane (AM) has varied applications in regenerative medicine. Over the years, its clinical applications have advanced from corneal and skin repair to solubilized powder injections, amniotic cytokine extract, and micronized dehydrated membrane to regenerate tendons, cartilage, and muscles. Also, AM is a source of several stem cells types and is a highly biocompatible natural scaffold. Thus, with the increasing number of reconstructive and cosmetic surgeries globally, the surgical wounds segment is expected to continue its revenue growth trend throughout the forecast period.

Some of the prominent and resurging AM applications are:

1. Ophthalmology

Ophthalmology is the fastest-growing segment in the amniotic membrane application market. It has become one of the key adjuvant treatments in ophthalmic surgery, with advancements in tissue engineering, ease of use, enhanced obtaining process, and tectonic properties. Additionally, tissue engineering has enabled its use in classic forms and drops.

2. Skin Graft

Amniotic membrane was first used as a skin substitute in 1910. As an alternative for the dressing of skin graft donor sites, it offers substantial benefits like decreased number of dressing changes and enhanced wound healing process.

Additionally, it has similar features as human skin since it originates from ectoderm. As per studies, it is further evaluated to prevent associated infections, traumas, and dehydration conventionally observed in disrupted skin wounds. Moreover, AM serves as a cost-efficient material for wound dressing.

3. Sports Medicine

AM has promising applications in sports medicine, since it is a source of highly organized collagen, matrix proteins, immunomodulators, anti-inflammatory and anti-fibrotic cytokines, and pluripotent cells. When applied as tissue engineering scaffolds, such aspects enhance tissue organization in treating and healing arthritic joints.

Also, around 14 companies offer commercial AM products despite sports medicine leaning towards animal and in vitro studies. Studies state that such products’ formulation changes their mechanical and biological properties, and an in-depth understanding of differences will enable the use of AM-derived products in sports medicine research.

Product Innovations: Amniotic Membrane Market Trend 2022

The development of various preservation methods has helped overcome AM’s limitations like high disease transmission risk and limited shelf life. Alongside, commercially available amniotic products implement dehydration preservation methods or cryopreservation methods to sustain the regenerative properties of amniotic membranes.

Moreover, there are over 80 commercial placenta membrane products available in the market. Some prominent firms operating in the market include Katena Products Inc, Bio-Tissue Inc, MIMEDX, Amino Technology LLC, etc.

The two leading AM products are cryopreserved AM and dehydrated AM, with the former harboring the largest revenue share in the product segment.

Dehydrated Amniotic Membranes

These are traditionally used in surgeries associated with ocular surface reconstruction. They are obtained from the human placenta surface after a healthy birth, wherein the donor tissue is evaluated for communicable diseases. However, matching donors is not a requisite since donor tissue is absorbed through the healing process.

In addition, dehydration enables AM tissue storage in a shelf-stable state and its active biological components preservation, required for medical uses. Dehydrated AM is used for several applications, the most common being treating neurotrophic corneal ulcer, a non-healing ocular surface defect. Besides, it can be employed to minimize scar tissue during ocular surface healing.

Cryopreserved Amniotic Membranes

These retain the specific biologic matrix that facilitates AM’s regenerative healing and anti-inflammatory properties, leading to fewer clinic visits and long-term relief. This is because cryopreserved amniotic membranes last longer on the eye. Also, these are FDA-approved for their anti-scarring and anti-angiogenesis properties. Moreover, cryopreserved AMs are advantageous compared to other therapies in terms of corneal defects.

The Progress Here on:

Amniotic membrane has had clinical applications for 100 years. Despite a slow start in clinical use, it has made inroads into several fields of medicine and surgery in the last 50 years. Besides, its beneficial properties and growing availability due to innovative storage methods offer lucrative growth opportunities for the global amniotic membrane market.

[market-research-future]

Amniotic Membrane Market Key Companies Profile, Sales and Cost Structure Analysis Till 2025

Market Highlights:

Amniotic Membrane is the inner layer of the placenta, which possesses various biological properties used to various defects, such as disorders of the outer eye, partial stem cell deficiency, corneal defects, chemical burns, conjunctivochalasis, pterygium, symblepharon, and various other ocular surface conditions. Amniotic membrane is used in various applications, such as regenerative medicine, ophthalmology, surgical wounds, and stem cell biology.

The Global Amniotic Membrane market is estimated to lead a healthy growth. The Global Amniotic Membrane market is majorly driven by increasing number of market players focusing on various applications of Amniotic Membrane, rising global aging population, increasing patient population, and rising healthcare expenditure. Varied applications of amniotic membrane are likely to drive the growth of global amniotic membrane market.

Additionally, rise in the number of amniotic membrane transplant performed, need for better and newer technologies, and improved healthcare facilities are propelling the growth of Global Amniotic Membrane market. Factors such as socio-ethical concerns and lack of awareness among mass is likely to hamper the growth of the Global Amniotic Membrane market. Global Amniotic Membrane market is expected to grow at a CAGR of 9.8% during the forecast period.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5645

Regional Analysis:

The Americas dominate the Global Amniotic Membrane market owing to the rising market players focusing on varied applications of amniotic membrane; the increasing geriatric population also leads to rising patient population. Additionally, rising number of amniotic membrane transplant and wide availability of medical device manufacturers and pharmaceutical & biotechnology companies are fuelling the growth of global amniotic membrane market. According to CDC, around 19.6% population in the U.S. is likely to be 56 years and older. This rising aging population will increase the patient population leading to growth in amniotic membrane market.

Europe accounts for a healthy market share due to factors such as rising healthcare networks and growing healthcare expenditure. Growing healthcare market and infrastructure is driving the Amniotic Membrane market in Europe. Additionally, according to Eurostat, Germany incurred healthcare expenditure over EUR 321 billion in 2014. Germany, France, and the U.K hold a significant share in the market due to the increasing demand for technologically advanced devices and treatment.

The Asia Pacific is expected to register the fastest growing rate for the Amniotic Membrane market. High growth rate is attributed to rising healthcare centers, skilled medical professionals, and rising standard of living. Additionally, rising patient population and demand for newer and better treatment is fuelling the market growth. India and China are the major contributors to the market growth due to the rapid development of healthcare sector and increasing healthcare infrastructure in these regions and increasing demand for new treatment services.

The Middle East & Africa is expected to witness limited growth due to limited access to healthcare services. In the Middle East, the growth of the market is driven by increasing healthcare infrastructre and demand for enhanced patient safety.

Key players

Derma Sciences Inc.

FzioMed, Inc.

Alliqua BioMedical

Skye Biologics Inc.

IOP Ophthalmics

Amniox Medical, Inc.

MiMedx Group, Inc.

Human Regenerative Technologies, LLC

Tissue-Tech Inc.

APPLIED BIOLOGICS

Amnio Technology

Segments:

The Global Amniotic Membrane market is segmented on the basis of type, application, and end-users. On the basis of type, the amniotic membrane market is segmented as lyophilized amniotic membrane, cryopreservation amniotic membrane, and others. On the basis of application, the amniotic membrane market is segmented into ophthalmology, surgical wounds, stem cell biology, and regenerative medicine.  On the basis of end-user the market is segmented into specialized clinics centers, hospitals, ambulatory surgical centers, research institutes, and laboratory.

BRIEF TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/amniotic-membrane-market-5645

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

…TOC CONTINUED

Browse Related Research Reports at:

Type 2 Diabetes Mellitus Treatment Market Research Report - Forecast to 2023 | MRFR

Hemophilia Treatment Market Overview, Size, Share, Growth and Industry Trends

Global Bariatric Surgery Market Size, Trends, Growth 2017-2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

[storesandmarket]

Abstract: Great success of the modern keratorefractive surgery and its wide spread require high attention to the biometric parameters of the eye in pre- and post-operation period. The most important parameters are those characterizing the cornea, such as central corneal thickness and its changes, regenerative response of corneal tissue and its regulation, as well as the intraocular pressure (IOP) and its correlation with corneal parameters. Morphological structure of the cornea is altered, during various, and first of all laser surgeries with refractive, reconstructive, optical and other purposes. For the patients after corneal surgery an accurate IOP measurement without corneal contact would be desirable. The transpalpebral transscleral tonometer Diaton is small and mobile. It is a non-corneal device, which allows for IOP-measurement in sitting and supine position. recording of stationary and expansive equipment like slit lamp and air puff machines, in seated or in lying position of the patient, and it is independent from mains supply. A resent clinical study revealed that the results of IOP measurement using transpalpebral transscleral tonometry in patients with refraction anomaly before and after keratophotorefractive surgery do not depend on central corneal thickness and are similar to CCT-corrected IOP-values measured by Goldmann Applanation Tonometry. A reproducibility study with Diaton showed recently that when performed by experienced or well-trained individuals, IOPmeasurements with Diaton possess high reproducibility and low inter-grader variability. Moreover the measuring method has been shown to be easy to learn over a short time. Clinical application of transpalpebral transscleral tonometry with Diaton makes IOP-measurement efficient and economical. No additional instrumental examination, like measurement of CCT is required.  This allows for the application of Diaton as a screening tonometry device both in clinical and non-clinical environment, as  well as in rural areas. A particular advantage of Diaton is its ability to measure IOP in situations of contraindication to the corneal tonometry, e.g., ulcer or IOP-monitoring after keratorefractive surg https://www.instagram.com/p/B0t0RRKBSnU/?igshid=10tgtsydliqvp

[priyanka16me]

Collagen and HA-Based Biomaterials Market to Observe Strong Development by 2020

Biomaterials are one of the most vital materials used in healthcare and pharmaceutical industry. They are natural or synthetic materials used for the development of synthetic organs, prosthetics, therapeutics and storage applications. They can be obtained from nature or synthesized in the laboratory with the aid of various chemical synthesis procedures.  Biomaterials are extensively used to replace or repair damaged tissues, such as bone and cartilage regeneration. Their wide areas of application include orthopedic surgery, dental surgery, cosmetic surgery, tissue regeneration, cardiovascular applications etc. There are three classes of biomaterials, namely, metallic biomaterials (stainless steels, titanium alloys etc.), ceramic biomaterials (bone and teeth implants) and polymer biomaterials (silicone, polyethylene etc.). Collagen is one of the most abundant form of protein in the human body, and use of these biomaterials in the tissue engineering has increased extensively. This is attributed by its features such as biodegradability, easy availability, versatility and biocompatibility.

GetResearchReport Overview@

https://www.transparencymarketresearch.com/collagen-ha-based-biomaterials.html

Collagen and HA-based biomaterials have potential applications in the field of regenerative medicines, personal healthcare, and development of prosthetics. Collagen based biomaterials can be segmented into four types which are as follows:

Urinary Incontinence

Corneal shields

Stress incontinence

Wound dressings

Hyaluronic acid (HA) is a substance which is naturally present in the human body with highest concentration in the eye and joints. It has wide applications in the field of osteoarthritis, eye surgery, plastic surgery, prevention of aging etc. The U.S. FDA has approved the use of HA during certain surgical procedures such as cataract removal, eye surgery, corneal transplantation and others. The HA-based biomaterials market can be segmented into three types which are as follows:

Facial dermal filters

HA soft tissue filters

HA-based visco supplements

Some of the driving factors for the growth of collagen and HA-based biomaterials are constant rise in geriatric population, increased preference for personal healthcare, continuous technological upgradation followed by heightened demand for anti-aging treatments. Working women and baby boomers constitutes prime target population of this market. Increasing incidences of osteoarthritis across the globe will further boost the application of these biomaterials. On the other hand, factors like restricted supply of biomaterials and increasing threat of substitutes may impede the growth of collagen and HA-based biomaterials market.

Request For the Customization @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1649

Geographically, North America holds a leading position with regards to collagen and HA-based biomaterials market followed by the European market. Some of the major factors responsible for the growth of this market in these regions are increasing prevalence of various diseases, development of new and technologically advanced products, use of single-injection visco supplement products, and increasing need of individuals to stay fit and healthy in their advancing years. Asia-Pacific is one of the most lucrative markets for the expansion of collagen and HA-based biomaterials. This region is growing and developing at a rapid pace. The prime reasons which will proliferate the growth of this market in the Asia-Pacific region are high market penetration, increasing demand for tissue regeneration in developing regions, increasing number of elderly people with chronic arthritis due to high population density in countries like China and India, increasing need of individuals to opt for anti-aging treatments in order to enhance their physical appearance, and rising disposable income of the people to spend on sophisticated and advanced technologies.

Get PDF Brochure for more Professional & Technical industry insights:

https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1649

Some of the market players operating in the collagen and HA-based biomaterials market are Abbott Laboratories, Sanofi, Bausch & Lomb, Life Core Biomedical, LLC, Allergan, Inc., Genzyme, Inc., Advance d Medical Optics, Regentis Biomaterial Ltd. and many others.

[futuremarketinsightsreports]

Amniotic Membranes Market Poised to Expand at 9.3% CAGR During 2018 – 2028

According to the latest market report published by Future Market Insights, titled ‘Global Amniotic Membrane Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028’, the global amniotic membrane market is expected to expand at a CAGR of 9.3% over the forecast period 2018–2028.

FMI estimates that the global market for amniotic membrane is to be valued at US$ 955.2 Mn in 2018 and is expected to expand at CAGR of 9.3% over 2018–2028, to surpass US$ 2,322 Mn by 2028 end. Based on product type, the cryopreserved amniotic membrane segment dominated the global amniotic membrane market, with over 70% value share in 2017. The segment is expected to grow at above 9% CAGR over the forecast period of 2018–2028. North America is expected to maintain its dominance in the global market due to regulatory approvals of several new products in the U.S.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5044

Population of all age groups has emerged as a prominent consumer base, characterised by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries. This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic with regard to increasing amniotic membrane transplants and increasing demand for amniotic membrane products around the world, particularly in North American countries. It is more than likely that over the span of the next four to five years, the companies focus on developing innovative products and designing market level strategies to leverage the potential opportunities emerging in parallel with growing human population with various chronic diseases.

Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membrane and lyophilized amniotic membrane have evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.

The global amniotic membrane market has been segmented on the basis of product type, application, end user and regions. Globally, cryopreserved amniotic membrane is the most attractive segment from manufacturers’ point of view. Cryopreserved amniotic membrane is majorly used in ocular surface eye surgery owing to its positive effect on wound healing due to its anti-inflammatory property. Among all end users of amniotic membrane, high demand for amniotic membrane is expected to come from the hospitals segment due to rising application of amniotic membrane in advanced surgical healing.

By volume, the global amniotic membrane market is expected to expand at 11.4% over the forecast period of 2018–2028. With nearly 43% market value share, North America dominated the global amniotic membrane market in 2017, partly due to penetration of newly approved products in the U.S. Western Europe, the second large market globally, with U.K., France and Germany being countries with high growth rates., is expected to gain 110 BPS in its market share over 2018–2028. APEJ is expected to be the third large market for amniotic membrane. APEJ and China collectively are expected to contribute over 15% share in the global market by 2028 over 2018.

The market for amniotic membrane is highly consolidated with top 5 players contributing over 60% of the revenue share in 2017. Examples of some of the key players identified in the global market are Integra LifeSciencesm Inc., MiMedx Group, Inc., Alliqua BioMedical, Inc., Skye Biologics Inc., Katena Products, Inc., Tissue-Tech Inc., Amnio Technology, LLC, Applied Biologics LLC, Human Regenerative Technologies, LLC, etc. Depth of research, along with proper documentation and statistical validation are factors that could determine a player’s success in the global amniotic membrane market.

Read Comprehensive Overview with Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-5044

Some of the key points identified in global amniotic membrane market are:

FMI forecasts the global amniotic membrane market to grow at a CAGR of 9.3% over the forecast period by 2028 end. The growth in revenue generation across the amniotic membrane market is registered on the account of rise in amniotic membrane transplants in both developed and developing economies.

The hospitals segment has proved to be the leading end user segment on account of increase in number of amniotic membrane transplants, growing awareness among the people about the benefits of the amniotic membrane transplant.

Ease of FDA approval for novel and innovative amniotic membrane allografts coupled with adoption of amniotic membrane for varied applications would boost the revenue growth in Germany & the U.S. markets.

Most often, apart from major applications including surgical wound and ophthalmology, the use of amniotic tissue in orthopaedic surgery, sports medicine and podiatry treatment has increased in the recent years.

The amniotic membranes used majorly to treat human surgical wound needs to be FDA approved, thus amniotic membrane manufacturers focus on getting fast FDA approvals.

[priyanka25universe-blog]

Collagen and HA-Based Biomaterials Market Will Reflect Significant Growth Prospects during 2014 - 2020

Biomaterials are one of the most vital materials used in healthcare and pharmaceutical industry. They are natural or synthetic materials used for the development of synthetic organs, prosthetics, therapeutics and storage applications. They can be obtained from nature or synthesized in the laboratory with the aid of various chemical synthesis procedures.  Biomaterials are extensively used to replace or repair damaged tissues, such as bone and cartilage regeneration. Their wide areas of application include orthopedic surgery, dental surgery, cosmetic surgery, tissue regeneration, cardiovascular applications etc. There are three classes of biomaterials, namely, metallic biomaterials (stainless steels, titanium alloys etc.), ceramic biomaterials (bone and teeth implants) and polymer biomaterials (silicone, polyethylene etc.). Collagen is one of the most abundant form of protein in the human body, and use of these biomaterials in the tissue engineering has increased extensively.

Get Research Report Overview @ https://www.transparencymarketresearch.com/collagen-ha-based-biomaterials.html

This is attributed by its features such as biodegradability, easy availability, versatility and biocompatibility. Collagen and HA-based biomaterials have potential applications in the field of regenerative medicines, personal healthcare, and development of prosthetics. Collagen based biomaterials can be segmented into four types which are as follows:

Urinary Incontinence

Corneal shields

Stress incontinence

Wound dressings

Hyaluronic acid (HA) is a substance which is naturally present in the human body with highest concentration in the eye and joints. It has wide applications in the field of osteoarthritis, eye surgery, plastic surgery, prevention of aging etc. The U.S. FDA has approved the use of HA during certain surgical procedures such as cataract removal, eye surgery, corneal transplantation and others. The HA-based biomaterials market can be segmented into three types which are as follows:

Facial dermal filters

HA soft tissue filters

HA-based visco supplements

Some of the driving factors for the growth of collagen and HA-based biomaterials are constant rise in geriatric population, increased preference for personal healthcare, continuous technological upgradation followed by heightened demand for anti-aging treatments. Working women and baby boomers constitutes prime target population of this market. Increasing incidences of osteoarthritis across the globe will further boost the application of these biomaterials. On the other hand, factors like restricted supply of biomaterials and increasing threat of substitutes may impede the growth of collagen and HA-based biomaterials market. Geographically, North America holds a leading position with regards to collagen and HA-based biomaterials market followed by the European market. Some of the major factors responsible for the growth of this market in these regions are increasing prevalence of various diseases, development of new and technologically advanced products, use of single-injection visco supplement products, and increasing need of individuals to stay fit and healthy in their advancing years. Asia-Pacific is one of the most lucrative markets for the expansion of collagen and HA-based biomaterials. This region is growing and developing at a rapid pace. The prime reasons which will proliferate the growth of this market in the Asia-Pacific region are high market penetration, increasing demand for tissue regeneration in developing regions, increasing number of elderly people with chronic arthritis due to high population density in countries like China and India, increasing need of individuals to opt for anti-aging treatments in order to enhance their physical appearance, and rising disposable income of the people to spend on sophisticated and advanced technologies.

Get PDF Brochure for more Professional & Technical industry insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1649

Some of the market players operating in the collagen and HA-based biomaterials market are Abbott Laboratories, Sanofi, Bausch & Lomb, Life Core Biomedical, LLC, Allergan, Inc., Genzyme, Inc., Advance d Medical Optics, Regentis Biomaterial Ltd. and many others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com

[joyyywd]

@Regrann from @corbylees2 - @Regrann from @blo.mcintosh1961.blo - There are no words for the state in which this poor senior was surrendered! At 9+ years old, he should be living a life of comfort with good food and a soft bed. Unforunately Jemson has been living a life of neglect and possibly pain. Yet he still allowed a full exam with no troubles. Please share and help give Jemson the life that he should have always had. SYRUS aka JEMSON – A1116295 Manhattan Center Unaltered Male BROWN / WHITE, AM PIT BULL TER MIX, About 9 years old Weight 35 lbs Surrendered as a STRAY on 06/23/2017, From NY 10458, DueOut Date 06/26/2017 Medical Behavior Evaluation GREEN Medical Summary 06/23/17 14:39 DVM Intake Exam Estimated age: 10-12 yrs Microchip noted on Intake? no History : stray Subjective: Observed Behavior – weak, allows full exam, food offered afterexam ate very well Objective T = P = 110 R = eupnic BCS 2/9 EENT: OU corneal opacity, AU waxy discharge non pruritis, no nasal discharge noted Oral Exam: dental tartar and calucli, pale pink takcy mm PLN: No enlargements noted H/L: NSR, 3/6 L sided heart murmru, CRT < 2, Lungs clear, eupnic ABD: Non painful, no masses palpated U/G: intact male MSI: Ambulatory x 4, crepitus in elbosx, decreased ROM in hips & stifles, generalized mm atrophy – 11x7cm multilobulated ulcerated purulent mass (califlower appearance) on R alteral thigh – 6x3cm smooth dermal/SQ haired mass on L ventral neck CNS: QAR, no CN deficits, CPs WNL Rectal: formed feces, prostate not palpable Assessment 3/6 hear murmur (r/o primary heart dz vs secondary to anemia/emaciation vs other) masses r/o benign vs malignant neoplasia emaciated dehydrated Plan 0.4ml Burorphanol IV 3-vew chest rads = multifocal pinpoint opacities diffusely distributed through lung lobes (r/o age related calcification) CBC: non regenerative anemia (r/o chronic dz vs recent blood loss vs other), low platelets (r/o artifact vs paraneoplastic vs other) Chem:: low Alb (r/o chronic inflammation vs recent blood loss vs other) hi Glob (r/o chronic inflammation) 300ml LRS SQ 35.7mg Rimadyl PO BID x 5d 250mg Clavamos PO BID x 5d Prognosis: fair to poor SURGERY: Permanent waiver due to